(a) | in paragraph 15, delete item (2); |
(b) | in paragraph 15, after item (6), insert — | 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one (also known as 3,4-Methylenedioxy-α-pyrrolidinohexanophenone or 3,4-MDPHP)”; |
|
|
|
(c) | in paragraph 15, after item (8AA), insert — | 2-(Butylamino)-1-phenylhexan-1-one (also known as N-Butylhexedrone or α‑Butylaminohexanophenone)”; |
|
|
|
(d) | in paragraph 17, after item (2A), insert — | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1H-indazole-3-carboxamide (also known as ADB-5-Bromo-INACA) and its bromo positional isomers in the 6-membered ring of the indazole structure”; |
|
|
|
(e) | in paragraph 17, after item (6G), insert — | 1-(1-(1-(4-Bromophenyl)ethyl)-piperidin-4-yl)-1,3-dihydro-2H-imidazol-2-one (also known as Brorphine) and its bromo positional isomers in the phenyl ring”; |
|
|
|
(f) | in paragraph 17, after item (8B), insert — | 2-(1-(Cyclohexylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-(Cyclohexylmethyl)-2-oxoindolin-3-ylidene)benzohydrazide or BZO-CHMOXIZID)”; |
|
|
|
(g) | in paragraph 17, after item (10C), insert — | N,N-Diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine (also known as Metonitazene) and its diethylamino structural isomers and their respective methoxy positional isomers in the phenyl ring and nitro positional isomers in the 6-membered ring of the benzimidazole structure”; |
|
|
|
(h) | in paragraph 17, after item (19), insert — | N-Ethyl-1-(3-fluorophenyl)propan-2-amine (also known as 3-Fluoroethamphetamine, 3‑Fluoroethylamphetamine or 3-FEA) and its fluoro positional isomers in the phenyl ring”; |
|
|
|
(i) | in paragraph 17, after item (19A), insert — | 2-(2-(1-(4-Fluorobenzyl)-1H-(6-hydroxyindol)-3-yl)acetamido)-3,3-dimethylbutanamide and its N‑(1-amino-1-oxohexan-2-yl) isomers and their respective fluoro positional isomers in the phenyl ring and hydroxy positional isomers in the 6‑membered ring of the indole structure |
| | 2-(2-(1-(4-Fluorobenzyl)-1H-indol-3-yl)acetamido)-3,3-dimethylbutanamide (also known as ADB-FUBIATA or FUB-ACADB or AD-18) and its N-(1-amino-1-oxohexan-2-yl) isomers and their respective fluoro positional isomers in the phenyl ring”; |
|
|
|
(j) | in paragraph 17, before item (20AB), insert — | 2-(1-(5-Fluoropentyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-(5-Fluoropentyl)-2-oxoindolin-3-ylidene)benzohydrazide or 5-Fluoro-BZO-POXIZID or 5F-BZO-POXIZID or MDA-19 5-fluoropentyl analogue or 5F-MDA-19) and its fluoro positional isomers in the pentyl group”; |
|
|
|
(k) | in paragraph 17, after item (22), insert — | 2-(1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide or BZO-HEXOXIZID or MDA-19)”; |
|
|
|
(l) | in paragraph 17, after item (25), insert — | 2-(1-(5-Hydroxyhexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-(5-Hydroxyhexyl)-2-oxoindolin-3-ylidene)benzohydrazide) and its hydroxy positional isomers in the hexyl group”; |
|
|
|
(m) | in paragraph 17, after item (27), insert — | 2-(1-(5-Hydroxypentyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-(5-Hydroxypentyl)-2-oxoindolin-3-ylidene)benzohydrazide) and its hydroxy positional isomers in the pentyl group”; |
|
|
|
(n) | in paragraph 17, after item (36), insert — | 2-(1-Pentyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-Pentyl-2-oxoindolin-3-ylidene)benzohydrazide or BZO-POXIZID or MDA-19 pentyl analogue or 5C-MDA-19)”; |
|
|
|
(o) | in paragraph 17, after item (37), insert — | 1-Phenyl-2-phenyl-2-(1-pyrrolidinyl)ethanone (also known as α-Pyrrolidino-2-phenylacetophenone or α-D2PV)”; |
|
|
|
(p) | in paragraph 19, after item (50), insert — | (1-(Pent-4-en-1-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (also known as XLR-11 N-(4-pentenyl) analogue or UR-144 N-(4-pentenyl) analogue)”; |
|
|
|
(q) | in paragraph 20, after item (9), insert — | 4-{3-[(1-Adamantyl)carbamoyl]-1H-indazole-1-yl}butanoic acid”; and |
|
|
|
(r) | in paragraph 20, after item (36), insert — | 2-[1-(5-Fluoropentyl)-1H-indole-3-carboxamido]-3-methylbutanoic acid”. |
|
|
|